Literature DB >> 12493535

The N-methyl-D-aspartate receptor subunit NR2B: localization, functional properties, regulation, and clinical implications.

Jennifer M Loftis1, Aaron Janowsky.   

Abstract

The N-methyl-D-aspartate (NMDA) receptor is an example of a heteromeric ligand-gated ion channel that interacts with multiple intracellular proteins by way of different subunits. NMDA receptors are composed of seven known subunits (NR1, NR2A-D, NR3A-B). The present review focuses on the NR2B subunit of the receptor. Over the last several years, an increasing number of reports have demonstrated the importance of the NR2B subunit in a variety of synaptic signaling events and protein-protein interactions. The NR2B subunit has been implicated in modulating functions such as learning, memory processing, pain perception, and feeding behaviors, as well as being involved in a number of human disorders. The following review provides a summary of recent findings regarding the structural features, localization, functional properties, and regulation of the NR2B subunit. The review concludes with a section discussing the role of NR2B in human diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12493535     DOI: 10.1016/s0163-7258(02)00302-9

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  110 in total

1.  Schaffer collateral and perforant path inputs activate different subtypes of NMDA receptors on the same CA1 pyramidal cell.

Authors:  Elda Arrigoni; Robert W Greene
Journal:  Br J Pharmacol       Date:  2004-05       Impact factor: 8.739

Review 2.  NMDA receptors and metaplasticity: mechanisms and possible roles in neuropsychiatric disorders.

Authors:  Charles F Zorumski; Yukitoshi Izumi
Journal:  Neurosci Biobehav Rev       Date:  2012-01-02       Impact factor: 8.989

Review 3.  Targeting the glutamatergic system to treat major depressive disorder: rationale and progress to date.

Authors:  Daniel C Mathews; Ioline D Henter; Carlos A Zarate
Journal:  Drugs       Date:  2012-07-09       Impact factor: 9.546

4.  Expression of the NR2B-NMDA receptor trafficking complex in prefrontal cortex from a group of elderly patients with schizophrenia.

Authors:  L V Kristiansen; B Bakir; V Haroutunian; J H Meador-Woodruff
Journal:  Schizophr Res       Date:  2010-03-29       Impact factor: 4.939

Review 5.  Bigenomic regulation of cytochrome c oxidase in neurons and the tight coupling between neuronal activity and energy metabolism.

Authors:  Margaret T T Wong-Riley
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

6.  UCH-L1 inhibition involved in CREB dephosphorylation in hippocampal slices.

Authors:  Min Xie; Shao-Hui Wang; Zhi-Min Lu; Ying Pan; Qi-Cai Chen; Xiao-Mei Liao
Journal:  J Mol Neurosci       Date:  2013-12-10       Impact factor: 3.444

7.  Allosteric modulation of GluN2C/GluN2D-containing NMDA receptors bidirectionally modulates dopamine release: implication for Parkinson's disease.

Authors:  X Zhang; Z-J Feng; K Chergui
Journal:  Br J Pharmacol       Date:  2014-08       Impact factor: 8.739

8.  Association of a glutamate (NMDA) subunit receptor gene (GRIN2B) with obsessive-compulsive disorder: a preliminary study.

Authors:  Paul D Arnold; David R Rosenberg; Emanuela Mundo; Subi Tharmalingam; James L Kennedy; Margaret A Richter
Journal:  Psychopharmacology (Berl)       Date:  2004-04-09       Impact factor: 4.530

9.  Nicotine-induced dopamine release in the nucleus accumbens is inhibited by the novel AMPA antagonist ZK200775 and the NMDA antagonist CGP39551.

Authors:  Alexander R Kosowski; Gvido Cebers; Aleta Cebere; Ann-Charlott Swanhagen; Sture Liljequist
Journal:  Psychopharmacology (Berl)       Date:  2004-04-16       Impact factor: 4.530

10.  Identification of a Novel Rat NR2B Subunit Gene Promoter Region Variant and Its Association with Microwave-Induced Neuron Impairment.

Authors:  Li-Feng Wang; Da-Wei Tian; Hai-Juan Li; Ya-Bing Gao; Chang-Zhen Wang; Li Zhao; Hong-Yan Zuo; Ji Dong; Si-Mo Qiao; Yong Zou; Lu Xiong; Hong-Mei Zhou; Yue-Feng Yang; Rui-Yun Peng; Xiang-Jun Hu
Journal:  Mol Neurobiol       Date:  2015-04-28       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.